SKI Market

Indian Indices

Nifty

24,712.05 -255.70
(-1.02%)

Sensex

80,786.54 -849.37
( -1.04%)

Bank Nifty

54,450.45 -688.85
( -1.25%)

Nifty IT

36,063.20 -216.85
( -0.60%)

Global Indices

Nasdaq

45,450.55 147.07
(0.32%)

Dow Jones

6,488.44 28.12
(0.44%)

Hang Seng

42,514.95 120.55
(0.28%)

Nikkei 225

9,255.50 -10.30
(-0.11%)

Forex

USD-INR

87.51 0.16
(0.19%)

EUR-INR

102.17 -0.20
(-0.19%)

GBP-INR

118.05 -0.04
(-0.04%)

JPY-INR

0.59 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

173.2662963

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

49.93

17837.06

EPS(TTM)

Face Value()

Div & Yield %

34.15

0.51

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	1200.09	1016.94	853.17	712.93	616.94	512.33
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1200.09	1016.94	853.17	712.93	616.94	512.33
Other Income	44.45	33.78	35.31	23.42	13.81	31.37
Stock Adjustments	14.79	12.08	15.63	23.98	39.05	4.85
Total Income	1259.33	1062.80	904.11	760.33	669.80	548.55
EXPENDITURE :
Raw Materials	320.30	241.28	195.84	187.99	150.61	134.79
Power & Fuel Cost	112.23	104.97	97.65	71.64	39.86	37.30
Employee Cost	138.93	123.05	110.28	95.69	69.47	62.24
Other Manufacturing Expenses	26.18	28.00	24.93	17.10	12.99	30.93
Selling & Administrative Expenses	99.31	91.08	82.93	67.90	44.87	31.74
Miscellaneous Expenses	11.09	8.46	13.20	22.66	10.26	15.65
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	708.03	596.83	524.84	462.99	328.05	312.65
Operating Profit	551.29	465.97	379.27	297.34	341.74	235.91
Interest	1.04	3.18	5.18	6.13	1.05	1.17
Gross Profit	550.25	462.79	374.09	291.21	340.69	234.74
Depreciation	54.37	53.59	54.03	50.05	27.52	21.25
Profit Before Tax	495.88	409.20	320.06	241.16	313.17	213.49
Tax	118.96	99.83	79.53	58.49	75.72	54.53
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	3.95	4.63	2.40	4.10	2.11	-10.00
Reported Net Profit	372.96	304.73	238.13	178.57	235.33	168.96
Extraordinary Items	16.58	10.48	2.70	3.86	5.24	17.47
Adjusted Net Profit	356.38	294.25	235.43	174.71	230.09	151.49
Adjustment below Net Profit	5.97	-0.01	0.26	-0.56	-0.04	-0.84
P & L Balance brought forward	1403.60	1170.33	985.51	878.02	648.43	560.85
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	91.54	71.45	53.56	70.52	5.71	80.55
P & L Balance carried down	1691.00	1403.60	1170.33	985.51	878.02	648.43
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	875.00	875.00	683.00	51.20	0.00	392.50
Dividend Per Share(Rs)	10.70	8.75	6.83	5.12	0.00	39.25
Earnings Per Share-Unit Curr	35.65	29.13	22.76	187.76	247.44	177.66
Earnings Per Share(Adj)-Unit Curr	35.65	29.13	22.76	187.76	247.44	177.66
Book Value-Unit Curr	173.27	145.80	123.50	1164.13	1051.11	809.71
Book Value(Adj)-Unit Curr	173.27	145.80	123.50	1164.13	1051.11	809.71

24,712.05 -255.70 (-1.02%)

80,786.54 -849.37 ( -1.04%)

54,450.45 -688.85 ( -1.25%)

36,063.20 -216.85 ( -0.60%)

45,450.55 147.07 (0.32%)

6,488.44 28.12 (0.44%)

42,514.95 120.55 (0.28%)

9,255.50 -10.30 (-0.11%)

87.51 0.16 (0.19%)

102.17 -0.20 (-0.19%)

118.05 -0.04 (-0.04%)

0.59 0.00 (-0.17%)